Literature DB >> 31169251

A rare case: Branch retinal vein occlusion associated with the use of tamoxifen.

Nebi Serkan Demirci1, Gokmen Umut Erdem1, Nil İrem Uçgun2, Yakup Bozkaya1, Nuriye Yildirim Ozdemir1, Mutlu Dogan1, Nurullah Zengin1.   

Abstract

Tamoxifen-induced ocular complications including cataracts, keratopathies, retinopathy, impaired visual acuity, ocular irritation, optical neuritis, and retinal vein occlusion are uncommonly reported in the literature. Herein, we report on a premenopausal patient with right-side breast carcinoma who received adjuvant tamoxifen therapy (20 mg/day) for 1.5 years and developed sudden visual loss. Fundal examination revealed an obstruction in the branch of the retinal vein. The diagnosis was confirmed by fluorescein angiography and optical coherence tomography. Thus, tamoxifen was switched to an aromatase inhibitor. Tamoxifen-induced ocular complications should be kept in mind when visual symptoms are seen in patients undergoing tamoxifen therapy. In such cases, a complete ocular examination should be performed.

Entities:  

Keywords:  Breast cancer; ocular toxicity; retinal vein occlusion; tamoxifen therapy

Mesh:

Substances:

Year:  2019        PMID: 31169251     DOI: 10.4103/0973-1482.204888

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination.

Authors:  Hayato Tanaka; Daisuke Nagasato; Shunsuke Nakakura; Toshihiko Nagasawa; Hiroyuki Wakuda; Akihiro Kurusu; Yoshinori Mitamura; Hitoshi Tabuchi
Journal:  Taiwan J Ophthalmol       Date:  2022-05-27

Review 2.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.